Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Fisher & Paykel Healthcare Corporation Limited (FPH) vs. Competitors

3 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
NZ:FPHFisher & Paykel Healthcare Corporation LimitedNZD 49.35NZD 29.03B61.6534.18%Strong BuyUnlock the NZ:FPH analyst price target with TipRanks PremiumNZ:FPHUnlock the NZ:FPH top-analyst price target with TipRanks Premium
NZ:EBOEBOS Group LimitedNZD 21.73NZD 4.54B16.73-25.40%Strong BuyUnlock the NZ:EBO analyst price target with TipRanks PremiumNZ:FPH vs NZ:EBOUnlock the NZ:EBO top-analyst price target with TipRanks Premium
NZ:PEBPacific Edge LimitedNZD 0.28NZD 341.52M-6.9260.82%HoldUnlock the NZ:PEB analyst price target with TipRanks PremiumNZ:FPH vs NZ:PEBUnlock the NZ:PEB top-analyst price target with TipRanks Premium
NZ:RYMRyman HealthcareNZD 1.88NZD 1.91B-11.19-33.10%Moderate BuyUnlock the NZ:RYM analyst price target with TipRanks PremiumNZ:FPH vs NZ:RYMUnlock the NZ:RYM top-analyst price target with TipRanks Premium
NZ:TRUTruScreen Group Ltd.NZD 0.01NZD 8.38M-2.58-47.37%―Unlock the NZ:TRU analyst price target with TipRanks PremiumNZ:FPH vs NZ:TRUUnlock the NZ:TRU top-analyst price target with TipRanks Premium
NZ:AFTAFT Pharmaceuticals Ltd.NZD 4.63NZD 485.57M32.3942.46%Moderate BuyUnlock the NZ:AFT analyst price target with TipRanks PremiumNZ:FPH vs NZ:AFTUnlock the NZ:AFT top-analyst price target with TipRanks Premium

Performance Comparison

-50%-25%0%25%50%75%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
NZ:FPHFisher & Paykel Healthcare Corporation Limited49.3512.4733.81%
NZ:EBOEBOS Group Limited21.73-5.85-21.20%
NZ:PEBPacific Edge Limited0.280.1057.14%
NZ:RYMRyman Healthcare1.88-0.99-34.49%
NZ:TRUTruScreen Group Ltd.0.01-0.01-41.18%
NZ:AFTAFT Pharmaceuticals Ltd.4.630.9124.43%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts